Purpose: to evaluate the role of magnetic resonance imaging (MRI) in evaluation of fetal urinary abnormalities with normal and abnormal volume amniotic fluid after ultrasound examination.
Choledochal cysts (CCs) are rare congenital anomaly with characterized dilatation of intra-or extrahepatic biliary duct or both. Prenatal diagnosis is increasing due to high resolution of ultrasound (US) and ultrafast sequences of magnetic resonance imaging (MRI) showing better delineation of the cyst to the adjacent structure. Considering the additional value of the fetal MRI report is still infrequent to confirm the CC case, we therefore report the type I of CC, which was previously diagnosed as a cystic biliary atresia (CBA) from US result. Postnatal MRI and histopathology prove it.
A giant lymphangioma at the neck, axillary, chest wall up to abdominal wall, and extension into upper thoracic cavity and the right upper extremity is reported. Ultrasound examination during antenatal care revealed huge cyst lesion with septation. Magnetic resonance imaging was performed at 36 weeks of gestation to determine tissue characteristic, evaluate tumor extension especially into thoracic chest cavity for looking any compression vital structure such as airways, vascular, therefore can prepare of technique delivery of the baby and surgical planning after birth as well. Tracheoesophageal displacement index (TEDI) was measured more than 12. Fetal karyotype shows male karyotype with double deletion on chromosome 17. The baby has been operated 3 times. Histopathological result was lymphangioma. Intralesional bleomycin of 0.5 mg/kg is given post operation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.